Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C46H77NO17.H3O4P |
| Molecular Weight | 1014.0953 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 21 / 21 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OP(O)(O)=O.[H][C@@]1(C[C@@](C)(O)[C@@H](O)[C@H](C)O1)O[C@@H]2[C@@H](C)O[C@@]([H])(O[C@H]3[C@@H](CC=O)C[C@@H](C)C(=O)\C=C\C(C)=C\[C@H](CO[C@@H]4O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]4OC)[C@@H](CC)OC(=O)C[C@@H](O)[C@@H]3C)[C@H](O)[C@H]2N(C)C
InChI
InChIKey=NBOODGNJLRRJNA-IAGPQMRQSA-N
InChI=1S/C46H77NO17.H3O4P/c1-13-33-30(22-58-45-42(57-12)41(56-11)37(52)26(5)60-45)18-23(2)14-15-31(49)24(3)19-29(16-17-48)39(25(4)32(50)20-34(51)62-33)64-44-38(53)36(47(9)10)40(27(6)61-44)63-35-21-46(8,55)43(54)28(7)59-35;1-5(2,3)4/h14-15,17-18,24-30,32-33,35-45,50,52-55H,13,16,19-22H2,1-12H3;(H3,1,2,3,4)/b15-14+,23-18+;/t24-,25+,26-,27-,28+,29+,30-,32-,33-,35+,36-,37-,38-,39-,40-,41-,42-,43+,44+,45-,46-;/m1./s1
| Molecular Formula | H3O4P |
| Molecular Weight | 97.9952 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C46H77NO17 |
| Molecular Weight | 916.1001 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 21 / 21 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionCurator's Comment: Description was created based on several sources, including https://www.elanco.us/labels/Swine/Tylan_Soluble.pdf
Curator's Comment: Description was created based on several sources, including https://www.elanco.us/labels/Swine/Tylan_Soluble.pdf
Tylosin (trade names Tylocine, Tylan) is a bacteriostat feed additive used in veterinary medicine. It has a broad spectrum of activity against Gram-positive organisms and a limited range of Gram-negative organisms. It is found naturally as a fermentation product of Streptomyces fradiae. It is a macrolide antibiotic. Tylosin is used in veterinary medicine to treat bacterial infections in a wide range of species and has a high margin of safety. Tylosin is certified by the FDA but is only approved for use in livestock such as cattle, chickens, swine, and turkeys. The FDA has prohibited the use of tylosin in dogs and cats, except where it is specifically prescribed by a veterinarian. Tylosin has a bacteriostatic effect on susceptible organisms, caused by inhibition of protein synthesis through binding to the 50S subunit of the bacterial ribosome.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: Mycoplasma sp. 1220 growth |
|||
Target ID: Staphylococcus aureus growth |
|||
Target ID: E. coli growth |
|||
Target ID: Streptococcus pneumoniae growth |
|||
Target ID: Pasteurella multocida growth |
|||
Target ID: Fusobacterium necrophorum growth |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | Tylan 200 Approved UseIn beef cattle and non-lactating dairy cattle, Tylan 200 Injection is indicated for use in the treatment of bovine respiratory complex (shipping fever, pneumonia) usually associated with Pasteurella multocida and Actinomyces pyogenes; foot rot (necrotic pododermatitis) and calf diphtheria caused by Fusobacterium necrophorum and metritis caused by Actinomyces pyogenes.
In swine, Tylan 200 Injection is indicated for use in the treatment of swine arthritis caused by Mycoplasma hyosynoviae; swine pneumonia caused by Pasteurella spp; swine erysipelas caused by Erysipelothrix rhusiopathiae; swine dysentery associated with Treponema hyodysenteriae when followed by appropriate medication in the drinking water and/or feed. Launch Date1.27543686E12 |
|||
| Curative | Tylan 200 Approved UseIn beef cattle and non-lactating dairy cattle, Tylan 200 Injection is indicated for use in the treatment of bovine respiratory complex (shipping fever, pneumonia) usually associated with Pasteurella multocida and Actinomyces pyogenes; foot rot (necrotic pododermatitis) and calf diphtheria caused by Fusobacterium necrophorum and metritis caused by Actinomyces pyogenes.
In swine, Tylan 200 Injection is indicated for use in the treatment of swine arthritis caused by Mycoplasma hyosynoviae; swine pneumonia caused by Pasteurella spp; swine erysipelas caused by Erysipelothrix rhusiopathiae; swine dysentery associated with Treponema hyodysenteriae when followed by appropriate medication in the drinking water and/or feed. Launch Date1.27543686E12 |
Sample Use Guides
In Vivo Use Guide
Curator's Comment: Can also be given orally https://www.elanco.us/labels/Swine/Tylan_Soluble.pdf
BEEF CATTLE AND NON-LACTATING DAIRY CATTLE—Inject intramuscularly 8 mg per pound of body weight one time daily (1 mL per 6.25 pounds). Treatment should be continued 24 hours following remission of disease signs, not to exceed 5 days.
SWINE—Inject intramuscularly 4 mg per pound of body weight (1 mL per 12.5 pounds) twice daily. Treatment should be continued 24 hours following remission of disease signs, not to exceed 3 days. Do not inject more than 5 mL per site.
Route of Administration:
Intramuscular
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 03:15:10 UTC 2023
by
admin
on
Sat Dec 16 03:15:10 UTC 2023
|
| Record UNII |
NR75X12AFF
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C261
Created by
admin on Sat Dec 16 03:15:10 UTC 2023 , Edited by admin on Sat Dec 16 03:15:10 UTC 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
215-779-4
Created by
admin on Sat Dec 16 03:15:10 UTC 2023 , Edited by admin on Sat Dec 16 03:15:10 UTC 2023
|
PRIMARY | |||
|
1363719
Created by
admin on Sat Dec 16 03:15:10 UTC 2023 , Edited by admin on Sat Dec 16 03:15:10 UTC 2023
|
PRIMARY | RxNorm | ||
|
C84235
Created by
admin on Sat Dec 16 03:15:10 UTC 2023 , Edited by admin on Sat Dec 16 03:15:10 UTC 2023
|
PRIMARY | |||
|
6440844
Created by
admin on Sat Dec 16 03:15:10 UTC 2023 , Edited by admin on Sat Dec 16 03:15:10 UTC 2023
|
PRIMARY | |||
|
1405-53-4
Created by
admin on Sat Dec 16 03:15:10 UTC 2023 , Edited by admin on Sat Dec 16 03:15:10 UTC 2023
|
PRIMARY | |||
|
NR75X12AFF
Created by
admin on Sat Dec 16 03:15:10 UTC 2023 , Edited by admin on Sat Dec 16 03:15:10 UTC 2023
|
PRIMARY | |||
|
300000023736
Created by
admin on Sat Dec 16 03:15:10 UTC 2023 , Edited by admin on Sat Dec 16 03:15:10 UTC 2023
|
PRIMARY | |||
|
NR75X12AFF
Created by
admin on Sat Dec 16 03:15:10 UTC 2023 , Edited by admin on Sat Dec 16 03:15:10 UTC 2023
|
PRIMARY | |||
|
DBSALT001662
Created by
admin on Sat Dec 16 03:15:10 UTC 2023 , Edited by admin on Sat Dec 16 03:15:10 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|